LRRK2 and neurodegenerative disease: As our previously published study30, we have suggested that LRRK2 R1628P variant could robustly increase the binding affinity of LRRK2 with Cyclin-dependent kinase 5 (Cdk5), a multifaceted kinase in neurodegenerative diseases.